medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2011, Número 96

<< Anterior Siguiente >>

Rev Enfer Infec Pediatr 2011; 24.25 (96)


Aspectos genómicos de Bordetella pertussis y el camino hacia el nuevo estándar de oro en el diagnóstico de tos ferina

Aquino AA, Martínez LG, de Colsa RA

Idioma: Español
Referencias bibliográficas: 32
Paginas: 139-146
Archivo PDF: 650.94 Kb.


FRAGMENTO

En plena era postvacunal, la tos ferina sigue siendo un problema endémico mundial, no sólo en países en vías de industrialización, sino también en los industrializados. En la última década ha resurgido como un problema de salud pública. En el mundo se registran cada año de 20 a 50 millones de casos que cobran la vida de 200,000-400,000 niños. El 90% de esas muertes son de pacientes que viven en países en vías de desarrollo, sobre todo lactantes menores de seis meses de edad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Beltrán Silva S, Cervantes Apolinar Y, Cherry JD, et al. Expert group on vaccinations for pertussis. Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Salud Publica Mex 2011;53:57-65.

  2. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr 2008;167:133-139.

  3. Preston A. Bordetella pertussis: the intersection of genomics and pathobiology. CMAJ 2005;173(1):55-62.

  4. Diavatopoulos DA, Cummings CA, Schouls LM, et al. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005;1(4):e45.

  5. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010;10(1):36-49.

  6. Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003; 35(1):32-40.

  7. Herrou J, Debrie A, Willery E, et al. Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella. PLoS ONE 2009;4(9):e6996.

  8. Preston A, Parkhill J, Maskell DJ. The bordetellae: lessons from genomics. Nat Rev Microbiol 2004;2(5):379-390.

  9. Mahillon J, Léonard C, Chandler M. IS elements as constituents of bacterial genomes. Res Microbiol 1999;150(9-10):675-687.

  10. Locht C. Bordetella: Molecular microbiology. Horizon Scientific Press; 2007.

  11. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2):326-382.

  12. Riffelmann M, Wirsing von König CH, Caro V, Guiso N. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005;43(10):4925-4929.

  13. Wendelboe AM, Van Rie A. Diagnosis of pertussis: a historical review and recent developments. Expert Rev Mol Diagn 2006;6(6):857-864.

  14. The Global Pertussis Initiative: Report from a Round Table Meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010. Vaccine 2011;29:1115-1121.

  15. Farrell DJ, McKeon M, Daggard G, et al. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J Clin Microbiol 2000;38(12):4499-4502.

  16. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 2001;39(5):1963-1966.

  17. Templeton KE, Scheltinga SA, van der Zee A, et al. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol. 2003;41(9):4121-4126.

  18. Probert WS, Ely J, Schrader K, et al. Identification and evaluation of new target sequences for specific detection of Bordetella Aquino AA, Martínez LG, de Colsa RA pertussis by real-time PCR. J Clin Microbiol 2008;46(10):3228- 3231.

  19. Qin X, Galanakis E, Martin ET, Englund JA. Multitarget PCR for diagnosis of pertussis and its clinical implications. J Clin Microbiol 2007;45(2):506-511.

  20. Furuya D, Yagihashi A, Endoh T, et al. Simultaneous amplification of Bordetella repeated insertion sequences and toxin promoter region gene by polymerase chain reaction. Immunopharmacol Immunotoxicol 1999;21(1):55-63.

  21. Fry NK, Duncan J, Wagner K, Tzivra O, et al. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 2009;58(Pt 8):1023- 1029.

  22. Tatti KM, Wu K, Tondella ML, et al. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis 2008; 61(3):264- 272.

  23. Bidet P, Liguori S, De Lauzanne A, Caro V, et al. Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis. J Clin Microbiol 2008;46(11):3636-3638.

  24. http://www.cdc.gov/pertussis/surv-reporting.html#case-definition

  25. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006;367:1926-1936.

  26. Hoppe JE, Weiss A, Wörz S. Failure of charcoal-horseblood broth with cephalexin to significantly increase rate of Bordetella isolation from clinical specimens. J Clin Microbiol 1988; 26(6):1248-1249.

  27. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977; 6(3):303-309.

  28. Katzko G, Hofmeister M, Church D. Extended incubation of culture plates improves recovery of Bordetella spp. J Clin Microbiol 1996;34(6):1563-1564.

  29. Current Methods for Diagnosis of Pertussis Infections. Tatti K., Pawloski L., Pittenger LG. Pertussis and Diphtheria Laboratory, Meningitis and Vaccine PreventableDisease Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/pertussis/lab.html.

  30. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999; 37(9):2872-2876.

  31. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von Konig CH; EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011;30(3):307-312.

  32. Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD; Pertussis Assay Working Group. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol 2009;16(12):1781-1788. REFERENCIAS




2020     |     www.medigraphic.com